Omics Global Solutions (OGS) borns as a company whose objective is to be the platform for development and launch of products related to "omics" sciences (proteomics, genomics, metabolomics, etc.) associated with innovative projects that have an impact on the lives of patients, their caregivers and medical professionals.
Located in Puerto Rico (USA), it's first milestone is the development and commercialization of one ELISA assay (INNOVATIO ND2™) based on IP Protected algorithm, for the risk identification of Diabetic Kidney Disease (DKD) using PromarkerD™ platform .
Being a Biotechnology company with development and commercial skills Omics is always open and seeking for strategic alliances for novel technologies with clear impact in the diagnostic field.
Company Details
- Employees
- 5
- Founded
- -
- Address
- San Juan, Pr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.omicssolutions.com
- HQ
- San Juan
Omics Global Solutions Questions
Omics Global Solutions's website is http://www.omicssolutions.com
Omics Global Solutions's LinkedIn profile is https://pr.linkedin.com/company/omics-global-solutions
Omics Global Solutions has
5 employees.
View email and phone details for 5
employees at Omics Global Solutions.
Omics Global Solutions's industry is
Biotechnology Research
Omics Global Solutions's top competitors are
Kamen&so,
Omics,
Laboratorio Clínico Colón,
Tuvidanews,
Proteomics And Modomics Experimental Core Facility (Promec),
Genomics Explained,
Omics Diagnostics Limited,
Genomics.ae,
Immuno Reference Lab,
Modaombre.
Omics Global Solutions's categories are Biotechnology Research
Omics Global Solutions's founding year is 2016
